Cicero AF, Fogacci F, Zambon A, Red Yeast Rice for Hypercholesterolemia: JACC Focus Seminar, «JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY», 2021, 77, pp. 620 - 628 [articolo]Open Access
Maloberti A, Bombelli M, Facchetti R, Barbagallo CM, Bernardino B, Rosei EA, Casiglia E, Cicero AFG, Cirillo M, Cirillo P, Desideri G, D'elia L, Dell'Oro R, Ferri C, Galletti F, Giannattasio C, Loreto G, Iaccarino G, Lippa L, Mallamaci F, Masi S, Mazza A, Muiesan ML, Nazzaro P, Parati G, Palatini P, Pauletto P, Pontremoli R, Quarti-Trevano F, Rattazzi M, Rivasi G, Salvetti M, Tikhonoff V, Tocci G, Ungar A, Verdecchia P, Viazzi F, Volpe M, Virdis A, Grassi G, Borghi C, Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study, «JOURNAL OF HYPERTENSION», 2021, 39, pp. 333 - 340 [articolo]
Elisa Russo, Francesca Viazzi, Roberto Pontremoli, Carlo M Barbagallo, Michele Bombelli, Edoardo Casiglia, Arrigo F G Cicero, Massimo Cirillo, Pietro Cirillo, Giovambattista Desideri, Lanfranco D'Elia, Raffaella Dell'Oro, Claudio Ferri, Ferruccio Galletti, Loreto Gesualdo, Cristina Giannattasio, Guido Iaccarino, Giovanna Leoncini, Francesca Mallamaci, Alessandro Maloberti , Stefano Masi, Alessandro Mengozzi, Alberto Mazza, Maria L Muiesan, Pietro Nazzaro, Paolo Palatini, Gianfranco Parati, Marcello Rattazzi, Giulia Rivasi, Massimo Salvetti, Valérie Tikhonoff, Giuliano Tocci, Fosca A L Quarti Trevano, Andrea Ungar, Paolo Verdecchia, Agostino Virdis, Massimo Volpe, Guido Grassi, Claudio Borghi, Serum Uric Acid and Kidney Disease Measures Independently Predict Cardiovascular and Total Mortality: The Uric Acid Right for Heart Health (URRAH) Project, «FRONTIERS IN CARDIOVASCULAR MEDICINE», 2021, 8, pp. 1 - 10 [articolo]Open Access
Muiesan ML, Salvetti M, Virdis A, Masi S, Casiglia E, Tikhonoff V, Barbagallo CM, Bombelli M, Cicero AFG, Cirillo M, Cirillo P, Desideri G, D'Eliak L, Ferri C, Galletti F, Gesualdo L, Giannattasio C, Iaccarino G, Mallamaci F, Maloberti A, Mazza A, Nazzaro P, Palatini P, Parati G, Pontremoli R, Rattazzi M, Rivasi G, Tocci G, Ungar A, Verdecchia P, Viazzi F, Volpe M, Grassi G, Borghi C, Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study, «JOURNAL OF HYPERTENSION», 2021, 39, pp. 62 - 69 [articolo]
Vahedian-Azimi A, Shojaie S, Banach M, Heidari F, Cicero AFG, Khoshfetrat M, Jamialahmadi T, Sahebkar A., Statin therapy in chronic viral hepatitis: a systematic review and meta-analysis of nine studies with 195,602 participants, «ANNALS OF MEDICINE», 2021, 53, pp. 1227 - 1242 [articolo]Open Access
Fogacci F, Borghi C, Di Micoli A, Cicero AFG, Sudden Fall in the Lipid- Lowering Effect of Evolocumab: The Butler Is Not Always Guilty, «MEDICINA», 2021, 57, Article number: 857, pp. 1 - 4 [articolo]Open Access
Zhubi-Bakija F, Bajraktari G, Bytyçi I, Mikhailidis DP, Henein MY, Latkovskis G, Rexhaj Z, Zhubi E, Banach M; International Lipid Expert Panel (ILEP); Cicero AFG, The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP)., «CLINICAL NUTRITION», 2021, 40, pp. 255 - 276 [articolo]Open Access
Agnoletti D, Cicero AFG, Borghi C, The Impact of Uric Acid and Hyperuricemia on Cardiovascular and Renal Systems., «CARDIOLOGY CLINICS», 2021, 39, pp. 365 - 376 [articolo]
Pugliese NR, Mengozzi A, Virdis A, Casiglia E, Tikhonoff V, Cicero AFG, Ungar A, Rivasi G, Salvetti M, Barbagallo CM, Bombelli M, Dell'Oro R, Bruno B, Lippa L, D'Elia L, Verdecchia P, Mallamaci F, Cirillo M, Rattazzi M, Cirillo P, Gesualdo L, Mazza A, Giannattasio C, Maloberti A, Volpe M, Tocci G, Georgiopoulos G, Iaccarino G, Nazzaro P, Parati G, Palatini P, Galletti F, Ferri C, Desideri G, Viazzi F, Pontremoli R, Muiesan ML, Grassi G, Masi S, Borghi C; Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension;, The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk, «CLINICAL RESEARCH IN CARDIOLOGY», 2021, 110, pp. 1073 - 1082 [articolo]Open Access
Cicero AFG, Fogacci F, Kuwabara M, Borghi C., Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: An Evidence-Based Update, «MEDICINA», 2021, 57, Article number: 58, pp. 1 - 18 [articolo]Open Access
2. Global Burden of Disease 2020 Health Financing Collaborator Network, Cicero AFG, Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050, «THE LANCET», 2021, 398, pp. 1317 - 1343 [articolo]Open Access
Piani F, Cicero AFG, Borghi C., Uric Acid and Hypertension: Prognostic Role and Guide for Treatment, «JOURNAL OF CLINICAL MEDICINE», 2021, 10, Article number: 448, pp. 1 - 15 [articolo]Open Access
Bianconi V, Banach M, Pirro M, International Lipid Expert Panel (ILEP) , Cicero AFG, Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levels, «TRENDS IN CARDIOVASCULAR MEDICINE», 2021, 31, pp. 205 - 215 [articolo]Open Access
Pecchioli V, Cicero AF, Lomartire N, Gemmiti MP, Colangeli A, Germanò R, Corsi MP, Germanò GIW, A double-blind, placebo-controlled clinical trial to assess the effects of a combined nutraceutical on endothelial function in patients with mild-to-moderate hypercholesterolaemia, «ARCHIVES OF MEDICAL SCIENCES. ATHEROSCLEROTIC DISEASES», 2020, 5, pp. 36 - 42 [articolo]
Cicero AFG, D'Addato S, Borghi C., A Randomized, Double-Blinded, Placebo-Controlled, Clinical Study of the Effects of a Nutraceutical Combination (LEVELIP DUO ®) on LDL Cholesterol Levels and Lipid Pattern in Subjects with Sub-Optimal Blood Cholesterol Levels (NATCOL Study), «NUTRIENTS», 2020, 12, Article number: 3127, pp. 1 - 10 [articolo]Open Access
